5Steen VD, Lucas M, Fertig N, et al. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody. J Rheumatol, 2007,34(11):2230-2235. 被引量：1
9Hirai Y, Iyoda M, Shibata T, et al. Lupus nephritis associated with positive MPO-ANCA in a patient with underlying autoimmune hemolytic anemia. Clin Exp Nephrol, 2008,10(2):380. 被引量：1
6Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum,1982,25 : 1271-1277. 被引量：1
7Bombardier C, Glandman DD, Urowitz MB, et al. Derivation of the SLEDAI: a disease activity index for lupus patients. The Committee on Prognosis in SLE. Arthritis Rheum, 1992, 35:630-640. 被引量：1
8Janwityanuchit S, Verasertniyom O, Vanichapuntu M, et al. Antisin: its predictive value in systemic lupus erythematosus. Clin Rheumtol, 1993, 12: 350-353. 被引量：1
9Cepeda EJ,Reveille JD.Autoantibodies in systemic sclerosis and fibrosing syndromes:clinical indications and relevance.Curr Opin Rheumatol,2004,16(6):723-732. 被引量：1
10Rands AL,Whyte J,Cox B,et al.MHC class II associations with autoantibody and T cell immune responses to the scleroderma autoantigen topoisomerase I.J Autoimmun,2000,15(4):451-458. 被引量：1
